Vivoryon Therapeutics N.V. (FRA:05Y)
Germany · Delayed Price · Currency is EUR 1.498
-0.012 (-0.79%)
At close: Jan 30, 2026
Vivoryon Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
44.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -3.62M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 10.76M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 1.22B |
| PEH Wertpapier AG | 183.79M |
| edding AG | 149.67M |
| Fernheizwerk Neukölln Aktiengesellschaft | 66.35M |
| Infas Holding AG | 63.66M |
| SBF AG | 46.20M |
| Alexanderwerk Aktiengesellschaft | 33.44M |
| Fair Value REIT-AG | 28.37M |